Global High Density Cell Banking Market Overview
High density (HD) cell banking involves the cell optimization and scaling-up processes. Seed train optimization is high density cell banking that involves larger volume frozen seed banks, elimination of seed steps from vial and allows banking of larger volumes up to 1 liter. Elimination of the intermediary is permitted on use of high density cell banking steps between cryovial thaws to bioreactor and allows seeding directly into the bioreactor. Advantages of this method include the ability to eliminate steps in the seed train process thereby reducing time to bioreactor and consistent inoculation across process runs.
Cell banking is basically a process of separation of cells and their storage that belongs to a specific genome which can be exercised in drug development, biological research, and medical use. High density (HD) cell banking technique is used to eliminate delay and reducing the chance of contamination. In this technique, the need for centrifugation and dilution processes are eliminated as the cells are distributed directly into single-use bioreactor or culture vessel which in turn speeds up the creation of homogenous cells.
Market Size & Forecast
High density cell banking market is anticipated to record a significant CAGR over the forecast period. Increasing applications and high adoption rate of high density (HD) cell banking techniques in research and academics globally is expected to propel the market during the forecast period. Development of improved technologies along with the entry of new players in the market of high density cell banking is predicted to create fierce competition over the forecast period in the market which is anticipated to help the market expand across the globe.
On the basis of regional platform, global high density cell banking market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America dominates the global high density (HD) cell banking market in terms of revenue generation followed by Europe. North America and certain parts of European regions are expected to witness significant growth due to increased adoption of high density (HD) cell banking and due to rising awareness in these regions.
Asia-Pacific is expected to witness significant growth as compared to other regions and countries owing to increase in spending in pharmaceutical sector and presence of several biotechnology and research and development institutions.
Market Segmentation
Our-in depth analysis of the global high density cell banking market includes the following segments:
By Cell type
- Human Cells
- Ovarian Cells
- Sperm
- Stem Cells
- Plant Cells
- Animal Cells
- Micro-organisms
- Others
By End-User Industries
- Pharmaceuticals Companies
- Academic Institutes
- Research Centers
- Biotechnology Companies
By Region
Global High density cell banking Market is further classified on the basis of region as follows:
- North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Growth Drivers & Challenges
The demand for High Density (HD) Cell Banking is powered by increasing research and development expenditure in medical and biotechnology industry. The growing life science industry and increasing applications of biological drugs derived through genetic engineering and cell culture techniques will further aid the high density cell banking market to grow. Rising demand in therapeutic areas for stem cell research like cancer and autoimmune diseases is predicted to enhance demand for high-density cell banking over the forecast period. High retention of the cells in high-density cell cultures, increases productivity due to which high density cell banking market is anticipated to observe healthy growth across the globe in the near future.
Moreover, the growing adoption of cell culture processes for manufacturing of industrial enzymes and other proteins in the developed and emerging economies as well as for the discovery of new regenerative and personalized medicines are expected to behave as certain more factors that are estimated to increase demand for high density cell banking globally over the forecast period. However, low awareness about technological advancements and lack of technical expertise in developing and under-developed regions is expected to hamper the growth in terms of revenue of the high-density cell banking market over the forecast period.
Top Featured Companies Dominating The Market
- Genzyme Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pall Corporation
- General Electric Company
- Sartorius AG
- REPLIGEN CORPORATION
- Merck Millipore
- Thermo Fisher Scientific Inc.
- Quest International B.V.
- Qiagen
